chr19-10987812-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_001387283.1(SMARCA4):​c.1006C>T​(p.Pro336Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,452,166 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P336T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

SMARCA4
NM_001387283.1 missense

Scores

2
13
4

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.76

Publications

2 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.1006C>T p.Pro336Ser missense_variant Exon 6 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.1006C>T p.Pro336Ser missense_variant Exon 6 of 35 ENST00000344626.10 NP_003063.2 P51532-1A7E2E1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.1006C>T p.Pro336Ser missense_variant Exon 6 of 36 NM_001387283.1 ENSP00000495368.1 Q9HBD4
SMARCA4ENST00000344626.10 linkc.1006C>T p.Pro336Ser missense_variant Exon 6 of 35 1 NM_003072.5 ENSP00000343896.4 P51532-1
SMARCA4ENST00000643549.1 linkc.1006C>T p.Pro336Ser missense_variant Exon 6 of 35 ENSP00000493975.1 A0A2R8Y4P4
SMARCA4ENST00000541122.6 linkc.1006C>T p.Pro336Ser missense_variant Exon 7 of 35 5 ENSP00000445036.2 P51532-4
SMARCA4ENST00000643296.1 linkc.1006C>T p.Pro336Ser missense_variant Exon 6 of 34 ENSP00000496635.1 P51532-4
SMARCA4ENST00000644737.1 linkc.1006C>T p.Pro336Ser missense_variant Exon 6 of 34 ENSP00000495548.1 P51532-4
SMARCA4ENST00000589677.5 linkc.1006C>T p.Pro336Ser missense_variant Exon 7 of 35 5 ENSP00000464778.1 P51532-3
SMARCA4ENST00000643995.1 linkc.418C>T p.Pro140Ser missense_variant Exon 3 of 32 ENSP00000496004.1 A0A2R8YGG3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.89e-7
AC:
1
AN:
1452166
Hom.:
0
Cov.:
34
AF XY:
0.00000139
AC XY:
1
AN XY:
721756
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33270
American (AMR)
AF:
0.00
AC:
0
AN:
43678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25876
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39306
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85132
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51128
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5574
European-Non Finnish (NFE)
AF:
9.02e-7
AC:
1
AN:
1108274
Other (OTH)
AF:
0.00
AC:
0
AN:
59928
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.67
D;.;T;.;.;.;.;.;.;.;D;.;.;.;.;.;T;T
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.87
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.37
D
MetaRNN
Uncertain
0.61
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.35
D
MutationAssessor
Uncertain
2.1
M;.;.;.;M;M;.;M;M;M;M;M;M;M;M;M;.;.
PhyloP100
7.8
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.0
D;.;.;.;.;.;.;.;.;.;D;.;D;.;D;.;D;D
REVEL
Uncertain
0.49
Sift
Benign
0.040
D;.;.;.;.;.;.;.;.;.;D;.;T;.;T;.;T;T
Sift4G
Benign
0.17
T;.;.;.;.;.;.;.;.;.;T;.;T;T;T;T;T;T
Polyphen
0.81
P;.;P;.;.;.;.;.;.;.;P;.;.;.;.;.;.;P
Vest4
0.72
MutPred
0.14
Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);Gain of phosphorylation at P336 (P = 0.0359);
MVP
0.68
MPC
0.59
ClinPred
0.96
D
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.24
gMVP
0.43
Mutation Taster
=45/55
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111491424; hg19: chr19-11098488; API